Medical specialties

Nodding off at the wheel? Not with these fatigue-sensing earbuds
UC Berkeley Engineers Develop Earbuds that Track Brain Signals Linked to Relaxation and Drowsiness Feeling sleepy during work is a common experience, especially after lunch. However, for individuals in high-risk jobs, like driving or operating heavy machinery, drowsiness can be perilous or even fatal. Drowsy driving alone contributes to hundreds of fatal traffic accidents every year across the U.S., and the National Safety Council has highlighted drowsiness as a critical risk in industries like
Nodding off at the wheel? Not with these fatigue-sensing earbuds
18 likes 900 views
UN dismisses nine employees for suspected links to October 7 Hamas attack on Israel
The United Nations has announced that it will end the employment of nine employees affiliated with the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA). This decision comes after an inquiry revealed possible connections between these individuals and Hamas-led attacks on Israel that took place on October 7. The investigation, led by the UN Office of Internal Oversight Services (OIOS), was initiated after accusations surfaced from Israel last year, alleging
42 likes 1 110 views
Aspirin May Offer the Greatest CRC Risk Reduction for Those in Poor Health
— The impact of aspirin on colorectal cancer risk lessens with healthier living A prospective cohort study has revealed that the regular use of aspirin is linked to a lower incidence of colorectal cancer (CRC), but this benefit appears more pronounced in those leading less healthy lifestyles. For healthcare professionals with the most unfavorable lifestyle scores, the 10-year cumulative rate of CRC was found to be 2.12% for consistent aspirin users, compared to 3.40% for those who did not
Aspirin May Offer the Greatest CRC Risk Reduction for Those in Poor Health
30 likes 1 328 views
Specialists Recommend Addressing These 14 Key Factors to Reduce Dementia Risk by Almost 50%
— Update from Lancet Commission incorporates vision loss, high LDL to risk factors PHILADELPHIA -- The Lancet Commission on dementia prevention, intervention, and care has expanded the list of modifiable risk factors linked to cognitive decline to 14, after new research conducted since its previous report in 2020. Vision loss and elevated low-density lipoprotein (LDL) cholesterol have been added to the commission's risk factor list, which previously included 12. This revised 57-page
52 likes 1 969 views
Processed Red Meat Tied to Increased Dementia Risk
— Replacing weekly servings of bacon or hot dogs with nuts and legumes linked to reduced dementia risk PHILADELPHIA – A long-term observational study involving 130,000 healthcare professionals found that eating processed red meat twice a week over several decades was associated with a higher likelihood of developing dementia. Participants from the Nurses' Health Study and the Health Professionals Follow-Up Study who consumed at least one-quarter of a daily serving of processed red meat —
79 likes 3 153 views
Insufficient Institutional Backing is a Leading Cause of Doctor Reluctance in Addressing Addiction
— Lack of Institutional Support and Knowledge rank as Key Factors A recent systematic review of 283 studies has determined that a lack of institutional backing remains the top reason clinicians hesitate to intervene in addiction cases, as highlighted by the findings. In their analysis, Wilson Compton, MD, MPE, deputy director of the National Institute on Drug Abuse (NIDA), and his colleagues reported in JAMA Network Open that 81.2% of the reviewed articles cited the institutional environment as
Insufficient Institutional Backing is a Leading Cause of Doctor Reluctance in Addressing Addiction
226 likes 9 439 views
If CD19 CAR T-Cell Therapy Doesn't Work in Lymphoma, Consider a CD22 Option
— Potential for durable responses with alternative antigen-targeted therapy A promising new treatment targeting a different antigen has shown success among patients with large B-cell lymphoma who previously relapsed after receiving CD19-directed CAR T-cell therapy (CAR19), according to findings from a phase I dose-finding study. In the study, 38 patients who had not responded to CAR19 achieved a 68% overall response rate and a 53% complete response rate following treatment with autologous
If CD19 CAR T-Cell Therapy Doesn't Work in Lymphoma, Consider a CD22 Option
278 likes 10 788 views